Friday, November 22, 2013

EU drugs agency says oral contraceptive benefits outweigh risks

An illustration picture shows a woman holding a pill at her home in Nice The benefits of combined hormonal contraceptive pills such as Bayer's Meliane or Yasmin in preventing unwanted pregnancies continue to outweigh any risk of blood clots, Europe's drugs regulator said on Friday. Announcing conclusions of a review into the safety of CHCs, the European Medicines Agency (EMA) said they carry a well-known but small risk of venous thromboembolism, or blood clots in the veins, and a "very low" risk of blood clots in arteries.








via Health News Headlines - Yahoo! News http://news.yahoo.com/eu-drugs-agency-says-oral-contraceptive-benefits-outweigh-131545287--finance.html

No comments:

Post a Comment